US Patent 10294304 Chimeric antigen receptors targeting B-cell maturation antigen
Patent 10294304 was granted and assigned to Pfizer Limited on May, 2019 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 10294304 Chimeric antigen receptors targeting B-cell maturation antigen
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
